The central melanocortin system can directly regulate serum insulin levels
The Precision Peptide Genetic Test reveals predispositions in key GLP-1 and GIPR pathways, which can inform how your body may respond to semaglutide therapy
The conversation covers how our understanding of obesity as a chronic, relapsing disease has changed over the past 30 years, what the new clinical versus preclinical obesity framework means for how we diagnose and treat it, how GLP-1 drugs work and why they've succeeded where earlier medications failed, what the STEP and SELECT trials revealed about the disease-modifying potential of semaglutide, and how patients and clinicians should be thinking about who these drugs are really for
By combining genetic insights with biomarker monitoring (glucose, A1c, lipids, inflammatory markers), you and your provider can evaluate whether your current dose schedule is achieving therapeutic benefit or whether adjustments warrant consideration
My mood has dramatically changed since taking this